Anthracycline-induced cardiomyopathy: secrets and lies-Reference-Cited by-同舟云学术

Anthracycline-induced cardiomyopathy: secrets and lies

Published:2018-03-01 Issue:5 Volume:20 Page:907-909
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Farmakis Dimitrios¹,Mantzourani Marina²,Filippatos Gerasimos¹³

Affiliation:

1. Cardio-Oncology Clinic, Heart Failure Unit, Department of Cardiology, Attikon University Hospital; National and Kapodistrian University of Athens Medical School; Athens Greece

2. First Department of Internal Medicine; Laiko Hospital, National and Kapodistrian University of Athens Medical School; Athens Greece

3. Universtiy of Cyprus Medical School; Nicosia Cyprus

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ejhf.1172/fullpdf

Reference12 articles.

1. Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care;Moor;Cancer Epidemiol Biomarkers Prev,2013

2. Abstract LB-339: Cause of death in cancer survivors [abstract];Ning;Cancer Res,2012

3. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC);Zamorano;Eur J Heart Fail,2017

4. Insights into onco-cardiology: atrial fibrillation in cancer;Farmakis;J Am Coll Cardiol,2014

5. Cancer drugs and the heart: importance and management;Suter;Eur Heart J,2013

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nano-emulsion based on Santolina chamaecyparissus essential oil potentiates the cytotoxic and apoptotic effects of Doxorubicin: an in vitro study;Journal of Microencapsulation;2024-08-02

2. Cardioprotective Effects of Leucine Supplementation against Doxorubicin-Induced Cardiotoxicity;Cardiovascular Toxicology;2024-01-02

3. Femtosecond laser-induced fluorescence for rapid monitoring of cardiac troponin 1 as a cardiovascular disease biomarker;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2024-01

4. State‐of‐the‐art document on optimal contemporary management of cardiomyopathies;European Journal of Heart Failure;2023-09-24

5. Chemotherapy-related cardiac dysfunction: the usefulness of myocardial work indices;The International Journal of Cardiovascular Imaging;2023-08-07